Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

  • 0Radiologie A, Assistance Publique - Hôpitaux de Paris, Cochin Hospital, Paris, France.

|

|

Summary

This summary is machine-generated.

A new radiomic signature, the SPECTRA Score, effectively predicts overall survival in metastatic colorectal cancer patients treated with FOLFIRI and bevacizumab. This tool offers earlier and more accurate outcome prediction than standard RECIST criteria.

Area Of Science

  • Radiology and Imaging
  • Oncology
  • Medical Statistics

Background

  • Metastatic colorectal cancer (mCRC) patients treated with FOLFIRI and bevacizumab require accurate early outcome prediction.
  • Standard criteria like RECIST 1.1 and morphological assessment have limitations in early prediction.

Purpose Of The Study

  • To develop and validate a radiomic signature for predicting early poor outcomes in mCRC patients.
  • To compare the predictive performance of this radiomic signature against RECIST 1.1 and morphological criteria.

Main Methods

  • An ancillary study of the PRODIGE-9 multicentre trial analyzed 230 mCRC patients.
  • Computed texture analysis of the dominant liver lesion (DLL) was performed at baseline and 2 months.
  • A radiomic signature (SPECTRA Score) was built using multivariable Cox analysis and validated in independent cohorts.

Main Results

  • The SPECTRA Score, combining decreased sum of target liver lesions, decreased kurtosis, and high baseline DLL density, predicted overall survival (OS).
  • Patients with a SPECTRA Score >0.02 had significantly lower OS across training, validation, and external cohorts.
  • The SPECTRA Score at 2 months showed prognostic value comparable to RECIST at 6 months.

Conclusions

  • A radiomic signature (SPECTRA Score) effectively predicts OS and identifies responders better than RECIST 1.1 in first-line mCRC treatment.
  • This radiomic tool shows promise for early outcome prediction in mCRC patients.
  • Further prospective studies are recommended for validation of the SPECTRA Score.

Related Concept Videos

Predicting Reaction Outcomes 02:24

10.4K

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...

Predicting Molecular Geometry 02:27

45.6K

VSEPR Theory for Determination of Electron Pair Geometries

The following procedure uses VSEPR theory to determine the electron pair geometries and the molecular structures:


Write the Lewis structure of the molecule or polyatomic ion.
Count the number of electron groups (lone pairs and bonds) around the central atom. A single, double, or triple bond counts as one region of electron density.
Identify the electron-pair geometry based on the number of electron groups: linear, trigonal planar,...

Outcomes of Glycolysis 01:13

106.8K

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08

265

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Prediction Intervals 01:03

3.3K

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 

Hepatic Portal System 01:21

5.6K

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...